Patent details

EP1392308 Title: OPHTHALMICALLY ACCEPTABLE COMPOSITIONS COMPRISING AN ALPHA-2-ADRENERGIC AGONIST AND A FATTY ACID

Basic Information

Publication number:
EP1392308
PCT Application Number:
PCT/US/2002/012219
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027288208
PCT Publication Number:
WO/2002/089804
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OPHTHALMICALLY ACCEPTABLE COMPOSITIONS COMPRISING AN ALPHA-2-ADRENERGIC AGONIST AND A FATTY ACID
French Title of Invention:
COMPOSITIONS OPHTHALMIQUES COMPRENANT UN AGONISTE ALPHA-2-ADRENERGIQUE ET UN ACIDE GRAS
German Title of Invention:
ZUSAMMENSETZUNGEN ENTHALTEND EINEN ALPHA-2-ADRENOREZEPTORAGONISTEN UND EINE FETTSAEURE
SPC Number:

Dates

Filing date:
17/04/2002
Grant date:
05/04/2006
EP Publication Date:
05/04/2006
PCT Publication Date:
14/11/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/03/2004
EP B1 Publication Date:
05/04/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/04/2006
Expiration date:
17/04/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/04/2002
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine, California 92612, United States (US)

Inventor

1

Name:
WOODWARD David, F.
Address:
United States (US)

2

Name:
AMBRUS Gyorgy
Address:
United States (US)

Priority

Priority Number:
848249
Priority Date:
03/05/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/495;
Filing date Document type Number of pages